Propizone 100 - Alphazone Pharmaceuticals

Originally intended to treat male hormone deficiency, Testosterone Propionate offered a breakthrough in the 1930s by enabling prolonged testosterone release. Launched in 1937 by Schering AG under Testoviron, it became the prototype for all testosterone esters. While FDA protocols came later, the drug was incorporated into approved treatments. Today, it serves both therapeutic and non-medical users. Due to suppression of natural testosterone, post-cycle therapy is necessary. Historically, it was the first injectable androgen standard.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Propizone 100 by Alphazone Pharmaceuticals, consult with your doctor or healthcare professional.